News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Oliger Christy J.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/26/2023 |
4
| Oliger Christy J. (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 5,565 shares
@ $0
Disposed/sold 1,250 options to buy
@ $92.2, valued at
$115.3k
Disposed/sold 10,000 options to buy
@ $92.2, valued at
$922k
Disposed/sold 106 options to buy
@ $92.2, valued at
$9.8k
Disposed/sold 5,000 options to buy
@ $146.01, valued at
$730.1k
Disposed/sold 180 options to buy
@ $146.01, valued at
$26.3k
Disposed/sold 5,620 options to buy
@ $34.76, valued at
$195.4k
Disposed/sold 2,137 options to buy
@ $93.61, valued at
$200k
|
|
| 06/09/2023 |
4
| Oliger Christy J. (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 1,682 shares
@ $93.61, valued at
$157.5k
Granted 2,137 options to buy
@ $93.61, valued at
$200k
|
|
| 05/25/2023 |
4
| Oliger Christy J. (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 34,000 options to buy
@ $2.5, valued at
$85k
|
|
| 04/04/2023 |
4
| Oliger Christy J. (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 25,200 options to buy
@ $17.66, valued at
$445k
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Oliger Christy J. (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 16,500 options to buy
@ $18.26, valued at
$301.3k
|
|
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/31/2020 |
4
| Oliger Christy J. (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 32,800 options to buy
@ $0 |
|
|
|